N-glycosylation is a common post-translational modification of G-protein-coupled receptors (GPCRs). However, it remains unknown how N-glycosylation affects GPCR signaling. b 2 adrenergic receptor (b 2 AR) has three N-glycosylation sites: Asn6, Asn15 at the N-terminus, and Asn187 at the second extracellular loop (ECL2). Here, we show that deletion of the N-glycan did not affect receptor expression and ligand binding. Deletion of the N-glycan at the N-terminus rather than Asn187 showed decreased effects on isoproterenol-promoted G-protein-dependent signaling, barrestin2 recruitment, and receptor internalization. Both N6Q and N15Q showed decreased receptor dimerization, while N187Q did not influence receptor dimerization. As decreased b 2 AR homodimer accompanied with reduced efficiency for receptor function, we proposed that the N-glycosylation of b 2 AR regulated receptor function by influencing receptor dimerization. To verify this hypothesis, we further paid attention to the residues at the dimerization interface. Studies of Lys60 and Glu338, two residues at the receptor dimerization interface, exhibited that the K60A/E338A showed decreased b 2 AR dimerization and its effects on receptor signaling were similar to N6Q and N15Q, which further supported the importance of receptor dimerization for receptor function. This work provides new insights into the relationship among glycosylation, dimerization, and function of GPCRs.
Introduction
G-protein-coupled receptors (GPCRs), also referred to as seven-transmembrane receptors, constitute the largest class of cell-surface receptors [1] . GPCRs can be activated by a variety of ligands, including odorants, chemokines, hormones, growth factors, and neurotransmitters [2] . The activated GPCR sequentially couples to multiple G proteins and triggers cell signaling by modulating the levels of cAMP, Ca 2+ , phosphatidylinositols, and other second messenger molecules [3] . Shortly afterward, agonist-occupied receptors are phosphorylated by G-protein-coupled receptor kinases, and then arrestin binds to the phosphorylated receptors, leading to receptor desensitization and internalization [4, 5] .
Various post-translational modifications of GPCRs, including phosphorylation, glycosylation, and fatty acid acylation [6] [7] [8] , are involved in receptor function regulation. Glycosylation is the most common posttranslational modification of cell-surface proteins in living cells [9] . In particular, N-linked glycosylation, which occurs exclusively at the consensus sequence NXT/S, is frequently observed at the N-terminal region and extracellular loops (ECLs) of GPCRs [7, 10] . Almost all of the class A GPCRs contain at least one N-glycosylation site at their N-terminal domains and 32% of them contain N-glycosylation sites at the second extracellular loop (ECL2) [11] .
It has been reported that N-glycosylation plays an important role in G-protein-dependent signaling and internalization of GPCRs, and the role of N-glycosylation in receptor function differs among GPCRs. For instance, deletion of the N-glycosylation sites of the protease-activated receptor-1 (PAR1) can affect thrombin-based G-protein signaling and the activated PAR1 internalization [12] . It was also reported that glycosylation of the human prostacyclin receptor was essential for agonist-induced G-protein signaling and iloprostmediated receptor internalization [13] . In endothelial differentiation gene-1 product, N-glycosylation does not affect agonist-induced MAP kinase activation but does decrease agonist-induced internalization [14] . Through the mutagenesis of glycosylation sites, it was revealed that the ECL2 N-glycan of PAR1 has complex effects on receptor signaling [12] . N-glycosylation at Asn123 of the calcitonin receptor-like receptor, but not at Asn66 or Asn118, is crucial for cAMP production [15] . Although a number of previous studies have suggested the importance of GPCR N-glycosylation on receptor function, the underlying molecular mechanism still remains ambiguous. b 2 adrenergic receptor (b 2 AR) is one of the prototypical models for structure-function studies of GPCRs [16] . In early studies, N-glycosylation of b 1 adrenergic receptor (b 1 AR) had no significant influence on receptor ligand binding or signaling, but it was reported to regulate receptor surface, dimerization might be through reducing receptor expression [17] . Rather than one glycosylation site (Asn15) on b 1 AR, b 2 AR has three N-glycosylation sites, Asn6, Asn15, and Asn187 [18] [19] [20] . These two receptors show distinct expression distribution, ligand recognition and biological functions [17] [18] [19] [20] . However, the mechanism of the glycosylation on b 2 AR function has not yet been well studied.
In this study, we sought to explain how b 2 AR N-glycosylation affects G-protein-dependent signaling, b-arrestin recruitment, and receptor internalization.
Results
N-glycosylation is not necessary for b 2 AR cellsurface expression in HEK293 cells N-Linked glycosylation of membrane proteins may be important for their folding and expression at the cell surface [21] . Several studies have suggested that NLinked glycosylation can influence the membrane expression levels of many GPCRs [12, 17] . Thus, we first examined the effects of N-glycosylation at Asn6, Asn15, and Asn187 on the membrane expression of b 2 AR. The cell-surface expression of b 2 AR was measured by monitoring the binding of a FITC-labeled antibody directed against the receptor N-terminal FLAG epitope. Mean FITC fluorescence intensity from the transfected cell population was used as a measure of receptor cell-surface expression. We tested four different transfection conditions: 0.5 lg plasmid/ 0.5 lL lipofectamine Upon analysis of cell-surface fluorescence, we could see the fluorescence signal amplified with the increase of the amount of plasmid, and the expression levels of all mutants were almost identical relative to the wildtype (WT) receptor under four different transfection conditions (Fig. 1) . These results suggested that N-glycosylation at Asn6, Asn15, and Asn187 is not essential for human b 2 AR cell-surface expression in HEK293 cells.
Mutagenesis of glycosylation sites at Asn6 and Asn15 influences b 2 AR signaling, b-arrestin recruitment, and internalization Based on the above results, we sought to investigate the role of glycosylation in b 2 AR signaling. By applying ligand-binding assay with Tag-lite beta adrenergic receptor green antagonist, green-propranolol, we found that the mutant receptors had similar binding affinity for green-propranolol compared with the WT receptor (Table 1) . Accordingly, we next examined the effect of N-glycosylation on the G-protein-dependent pathway by testing cAMP accumulation of b 2 AR induced by isoproterenol, a prototypical full agonist of the receptor. Peptide-N-glycosidase F (PNGase F, EC 3.2.2.11) is an amidase that cleaves the amide bond between the innermost N-acetylglucosamine and asparagine residues releasing high mannose as well as hybrid and complex oligosaccharides from N-linked glycoprotein [22] . After PNGase F digestion, the N-glycosylation of b 2 AR was deleted, thus resulted in approximate a 10-fold increase in the EC 50 of isoproterenol-induced cAMP accumulation ( Fig. 2A,C) . Next, we tried to explore the respective role of Nglycosylation at different sites in receptor activation. The WT and mutant receptors showed different efficiency in cAMP production upon ligand exposure (Fig. 2B) . Compared with the WT receptor, the mutant N6Q, N15Q, N6Q/N15Q, N6Q/N187Q, N15Q/N187Q, and N6Q/N15Q/N187Q all showed a significant increase in EC 50 values for isoproterenol (Fig. 2B,C) . However, the EC 50 value of isoproterenol for N187Q was not significantly different from the WT (Fig. 2C) . These results suggested that the N-glycosylation at Asn6 and Asn15 but not at Asn187 could affect the efficiency of isoproterenol-induced b 2 AR activation.
In addition to G protein, the intracellular side of GPCRs can also bind to arrestin. The two nonvisual arrestins, b-arrestin1 and 2, can regulate most GPCR family members [23] . b 2 AR internalization is primarily mediated by b-arrestin2 [5, 24] . Thus, we investigated the role of N-glycosylation in b-arrestin2 recruitment and receptor internalization. b-arrestin2-GFP translocation was assessed by confocal microscopy in HEK293 cells. Before isoproterenol stimulation, the barrestin2-GFP was uniformly distributed in the cytoplasm (Fig. 3A) . Figure 3A shows the translocation of b-arrestin2-GFP in HEK293 cells co-expressing the WT b 2 AR, N6Q, N15Q, N187Q, or N6Q/N15Q under conditions of agonist exposure (10 lM isoproterenol) at 37°C for 1 min and 20 min. At 1 min, the recruitment of b-arrestin2-GFP to N187Q was comparable to the WT. In contrast, the cells expressing N6Q, N15Q, and N6Q/N15Q showed less robust plasma membrane translocation upon isoproterenol stimulation in comparison with cells expressing the WT b 2 AR (Fig. 3A) . Upon agonist stimulation for 20 min, the WT b 2 AR and the mutants were internalized into the cytoplasm (Fig. 3A) .
Receptor internalization was assessed by flow cytometry. After incubation with 10 lM isoproterenol, for the WT and N187Q, receptor agonist stimulated, respectively, 33.43 AE 2.49% and 30.39 AE 2.48% receptor internalization (Fig. 3B) . Whereas for N6Q, N15Q, and N6Q/N15Q, isoproterenol induced (Fig. 4) . After PNGase F digestion, for the WT and mutants several bands around 46 kDa, in agreement with the monomer size, turned into one straight density band, indicating that the deglycosylated b 2 AR mainly retained as a monomer; for the WT and N187Q b 2 AR, the high molecular mass band (~100 kDa) nearly disappeared (Fig. 4) . Whereas, after endo-b-N-acetylglucosaminidase A (Endo-A, EC 3.2.1.96) incubation, which cleaves highmannose type and hybrid type N-glycans [25] , for the WT, there was no significant difference in bands at 46 kDa and~100 kDa (Fig. 4) . Then, in order to investigate whether the N-glycosylation at distinct sites could have different influence on receptor dimerization, we investigated the dimerization of the WT receptor and the mutants at cell membrane in the presence of a cellimpermeable covalent crosslinking reagent BS 3 . After incubation with 1 mM BS 3 , the covalently linked dimer form of the WT b 2 AR showed a high-density band at~100 kDa. Conversely, for the N6Q, N15Q, N6Q/N15Q, N6Q/N187Q, and N15Q/N187Q mutants, the 100-kDa bands almost disappeared; for the single mutant N187Q, this band remained comparable intensity compared with the WT (Fig. 5A ). In addition, several bands at~46 kDa were observed as the major bands for the N6Q, N15Q, N6Q/N15Q, N6Q/N187Q, and N15Q/N187Q mutants (Fig. 5A) . Consistent with position 6, 15, and 187 being glycosylated, the mutant receptors had lower apparent molecular mass at~46 kDa compared with the WT (Fig. 5A) . These data might demonstrate that the N-glycosylation at Asn6 and Asn15 might be crucial for receptor dimerization.
To further soundly prove b 2 AR homodimerization of the WT and mutants at HEK293 cell surface, FLAG-b 2 AR and HA-b 2 AR were expressed in HEK293 cells either individually or in combination with each other. As shown in Fig. 5B , for the WT and N187Q, when the FLAG-tagged b 2 AR were immunoprecipitated with an anti-FLAG antibody, the co-transfected HA-b 2 AR was robustly co-immunoprecipitated and specific immunoreactivity was observed at~100 kDa and below 55 kDa (Fig. 5B) . The band 50 of isoproterenol at the WT b 2 AR and mutants. *P < 0.05; **P < 0.01, and ***P < 0.001 versus the WT. The histograms represent the mean AE SEM (error bars) of three independent experiments done in duplicate.
below 55 kDa was not the IgG heavy chain or nonspecific pull-down of the HA receptor with the anti-FLAG antibody as this band is absent from the control lanes of the cells which were transfected with either HA-b 2 AR or FLAG-b 2 AR individually (Fig. 5B) . These results showed that there were two kinds of receptor dimers: an SDS-resistant dimer at 100 kDa and an SDS-sensitive dimer below 55 kDa. However, for N6Q and N15Q, there were only bands below 55 kDa after immunoprecipitation (Fig. 5B) . These results might exhibit that the receptor could only form the SDS-sensitive dimer after deletion of the N-glycosylation at the N terminal of b 2 AR. When FLAG-b 2 AR or HA-b 2 AR was transfected alone, there was no co-immunoprecipitation with the FLAGtagged receptor (Fig. 5B ). In the related control experiments, HA-b 2 AR and FLAG-b 2 AR were transfected separately into different plates of cells, which were harvested, prepared the cell membrane, and then mixed together before solubilization.
Immunoprecipitation of FLAG-b 2 AR in this experiment did not yield any detectable co-immunoprecipitation of HA-b 2 AR (Fig. 5B) , revealing that the dimerization of b 2 AR could be observed only in cells co-expressing both receptors and was not induced during the solubilization/immunoprecipitation procedures. Finally, the receptor homodimer levels at living cells membrane were tested by the Tag-lite assay, a timeresolved fluorescence resonance energy transfer assay which is widely used to investigate GPCR cell-surface dimerization [26] [27] [28] [29] . There was no difference between the dimerization signals of WT and N187Q, while the dimerization signals of N6Q, N15Q, N6Q/N15Q, N6Q/N187Q, and N15Q/N187Q were significantly reduced (Fig. 5C ). Lumi4 Ò -Tb fluorescence at 620 nm represented the expression level of the tagged receptor at the cell surface. Tb fluorescence signal showed that the tagged mutants had approximately equivalent expression levels at cell membrane compared with the WT (Fig. 5D ). The signals of N6Q and N15Q were stronger than the control (Fig. 5C ,E), thus we could speculate that deletion of the N-glycosylation at N-terminus only partially reduced receptor dimerization. After PNGase F digestion, the dimerization signals of the WT b 2 AR and the mutants decreased remarkably (Fig. 5E ). In contrast, after Endo-A incubation, there was no significant decrease in receptor dimerization signal versus the control b 2 AR (Fig. 5E ). Endo-A cleaves high-mannose type and hybrid type N-glycans, and PNGase F can release almost all kinds of N-glycans. Therefore, these data suggested the absence of high-mannose and hybrid type N-glycosylation on b 2 AR or weak influence of these types N-glycans in receptor dimerization.
Validation of the relationship between dimerization and receptor function by intracellular residue mutations
The above results suggested that deletion of the N-glycosylation at Asn6/15 could influence G-proteindependent signaling and receptor internalization; meanwhile, it could reduce receptor dimerization. Thus, we speculated that the glycosylation at Asn6/15 might modulate b 2 AR function by influencing receptor dimerization. This will be a reasonable hypothesis if decreasing receptor dimerization through the other way shows similar effects on receptor function.
In the crystal structure of the b 2 AR dimer, two amino acids, K60 and E338, directly form salt bridges in the dimer interface [30] , which may be important for receptor dimerization. Mutation of Lys60 and Glu338 had no significant effect on receptor cell membrane expression (Fig. 6A ) and ligand-binding affinity (Table 1) . After PNGase F digestion, the molecular weight of K60A/E338A was lower than the nondigested one (Fig. 7A) . It has been reported that reducing agent could disrupt P2Y12 oligomer form [31] . In our study, K60A/E338A exhibited almost none dimer compared with the WT (Fig. 7A) . In order to explore the authenticity of it, we investigate the effect of DTT, reducing agent in the loading buffer, on the dimer form of K60A/E338A. The four lanes of K60A/ E338A represented extracts from cells expressing K60A/E338A subjected to SDS/PAGE under four reducing conditions. There seems to have no significant difference between the 0 mM and 100 mM (Fig. 7A) . Thus, we can conclude the dimerization of K60A/E338A had nothing to do with the reducing condition.
Using the BS 3 crosslinking method, K60A/E338A showed a lower intensity dimer band at~100 kDa compared with the WT, while the monomer bands intensity at~46 kDa was comparable to the WT (Fig. 7B) . The molecular weight of K60A/E338A at 46 kDa was bigger than N6Q and N15Q (Fig. 7B ). These results meant that K60A/E338A was glycosylated. In co-immunoprecipitation experiment, K60A, E338A, and K60A/E338A exhibited significant less density band at~100 kDa than the WT, while the bands at 46 kDa were comparable with the WT (Fig. 7C ). These results showed that the double-mutant K60A/ E338A could not form the SDS-resistant dimer.
Furthermore, in the Tag-lite assay, the signal of K60A/E338A exhibited a significant reduction versus the WT receptor (Fig. 7D) . Meanwhile, the signal of K60A/E338A was stronger than the control, meaning that the mutant only partially disrupted receptor dimerization. Tb fluorescence signal at 620 nm for the mutants showed no significant difference compared with the WT (Fig. 7E) . Our experiments validated that the double-mutant K60A/E338A did decrease receptor dimerization. Moreover, the mutant showed a dramatically lower efficiency in response to isoproterenol in cAMP production than the WT (Fig. 6B,C) . In addition, K60A/E338A showed less robust b-arrestin2 recruitment compared with the WT receptor and 9.83 AE 1.50% receptor internalization upon isoproterenol stimulation (Fig. 6D,E) . These data revealed that deletion of the N-glycosylation at N-terminus and the double-mutant K60A/E338A had similar effects on receptor dimerization, G-protein-dependent signaling, b-arrestin2 recruitment, and receptor internalization. Therefore, b 2 AR dimerization might play a key role in regulating receptor function.
Discussion
In this work, the results of our experiments suggested that N-glycosylation does not affect synthesis or membrane expression of b 2 AR. The mutant receptors also showed similar efficiency to the WT receptor in ligand binding. Thus, we explored the role of N-glycosylation in receptor function. b 2 AR from tunicamycin-treated cells exhibits impaired adenylate cyclase activity in reconstituted lipid vesicles [19] . After PNGase F digestion, we found that the EC 50 of isoproterenol for cAMP generation increased about ten-fold (Fig. 2C) . This phenomenon indicated that deletion of N-glycans might affect b 2 AR intracellular conformation which caused the EC 50 of isoproterenol in cAMP production increased. Both tunicamycin and PNGase F treatment can delete all of the glycans on the cell surface, so we cannot distinguish the role of each glycosylation site exactly. Therefore, we next combined site-directed mutation and glycosidase experiments to investigate the role of each glycosylation site in determining b 2 AR function. The results of these experiments suggested that N-glycan at different sites might have distinct roles in human b 2 AR function. Deletion of the glycosylation at Asn6/15 rather than Asn187 could significantly decrease cAMP accumulation, b-arrestin2 recruitment, and receptor internalization.
Then, we studied the mechanism underlying the influence of the glycosylation at Asn6/15 on modulating receptor functions. Our results from crosslinking, co-immunoprecipitation, and Tag-lite assays supported that the WT b 2 AR could constitutively form dimer [32] [33] [34] [35] . N6Q and N15Q showed similar effects on receptor function. Meanwhile, we found that both N6Q and N15Q significantly decreased receptor dimerization. N187Q did not remarkably affect receptor function. Interestingly, this mutation also had no influence on receptor dimerization. Based on these results, we proposed that the N-glycosylation of b 2 AR regulated receptor function by influencing receptor dimerization.
In the presence of cholesterol, crystal packing of b 2 AR shows the significant involvement of the hydrophobic molecule in the intermonomer interface. In this framework, protein-protein contacts are minimal and include a pair of salt bridge between K60 and E338 from H8 [30] . In the crystal structure of b 2 ARGs protein complex, K60 and E338 do not participate in receptor-G s protein direct interaction [36] . For rhodopsin-arrestin complex structure, TM1 and H8 do not form the interaction interface [37] . Thus, there is no evidence that K60 and E338 can affect receptor coupling with G protein and arrestin. Similar to N6Q and N15Q, we found that the double-mutant K60A/ E338A exhibit remarkably less receptor dimerization (Fig. 7B-D) . If the N-glycosylation of b 2 AR regulates receptor function through influencing receptor dimerization, disruption of receptor dimerization by the mutant K60A/E338A may have effects on GPCR functions similar to N6Q and N15Q. Indeed, our experiments suggested that K60A/E338A significantly decreased agonist-induced cAMP production, arrestin recruitment, and receptor internalization. These results supported the hypothesis that the N-glycosylation of It has been reported that b 2 AR is able to form SDS-resistant [38] and SDS-sensitive homodimers [32] . In our co-immunoprecipitation experiments, the anti-HA antibody did not only visualize the expected higher molecular mass receptor at~100 kDa but also the monomeric receptor species (Figs 5B and 7C) . These results might show that b 2 AR can form homodimer through SDS-sensitive interactions and that the N-glycosylation at Asn6/15 was essential for receptor dimer stability. N6Q and N15Q only partially discomposed receptor dimer (Fig. 5C,E) . Combined with the results shown in Fig. 5B , we could conclude that deletion of the N-glycosylation at Asn6/15 only disrupted the SDS-resistant receptor dimer and it seemed that the SDS-resistant dimer was correlated with reduced efficiency in receptor function for N6Q and N15Q. Therefore, the mutants N6Q and N15Q may be effective tools to investigate the functional differences between the two kinds of b 2 AR dimers. Similar to N6Q and N15Q, the mutant K60A/E338A also disrupted the SDS-resistant dimer. Thus, the crystal structure of the dimeric b 2 AR [30] may represent the SDS-sensitive dimer form.
Our results suggested that decreased b 2 AR homodimer accompanied with reduced efficiency for G-protein-dependent signaling. However, this does not mean that receptor monomer cannot bind to downstream proteins. Monomeric b 2 AR incorporated into reconstituted high-density lipoprotein was found to couple with G protein following exposure to isoproterenol [39] . However, in vitro study cannot represent the real process in cell. Based on our results, we speculated that receptor homodimer might synergistically affect the binding of G protein. Thus, the homodimer may be more efficient in activating G-protein-dependent signaling than the monomer.
The mutants N6Q and N15Q only removed N-glycans at these two specific glycosylation sites of b 2 AR, while PNGase F treatment not only cleaved all accessible N-glycans of b 2 AR but also deglycosylated the whole N-glycans of entire cell-surface glycoproteins. We observed the decreased EC 50 values of isoproterenol in mutated b 2 ARs and more significantly decreased EC 50 after PNGase F digestion (Fig. 2C) . This result is probable due to the thorough deglycosylation on cell surface by PNGase F that may cause dysfunction or partially dysfunction of other related proteins in b 2 AR signaling pathway.
The PNGase F digestion was processed after the cells were digested by nonenzyme cell dissociation solution, meaning that the enzyme cannot process all the receptor residing in intracellular domains. Whole cell lysate samples were examined by western blot; interestingly, the~100 kDa band was disappeared (Figs 4 and 7A) . These results might indicate that the intracellular b 2 AR does not form dimer or that the intracellular b 2 AR homodimer was destroyed in the process of western blot. For b 2 AR, cell fraction studies revealed that receptor homodimerization occurs early in ER [40] .
It is widely accepted that the glycosylation of the ECL2 of GPCRs may play a role in stabilizing the conformation of the loop or may orient the loop away from the binding pocket entrance to enable unhindered ligand access [11] . In some GPCRs, ECL2 glycosylation can affect receptor folding and normal function [41, 42] . However, in our study, deletion of the N-glycosylation at the ECL2 of b 2 AR showed no effect on receptor expression, G-protein-dependent signaling, b-arrestin recruitment, receptor internalization, and dimerization. Previous study has suggested that the glycosylation of ECL2 in b 2 AR may have other effects on receptor function [20] .
b 1 AR and b 2 AR are the two major subtypes of the b-adrenergic receptor and are indispensable for normal cardiac physiological function and pathology [43] . b 1 AR shares high similarity with b 2 AR in sequence and structure. However, b 1 AR and b 2 AR play distinct and sometimes opposing roles in both cardiovascular physiology and the pathogenesis of heart failure [44, 45] . Meanwhile, there are significant differences between b 1 AR and b 2 AR in glycosylation. Glycosylation may be an important element in determining the diversity of the two subtypes. The N15A b 1 AR exhibits less cell-surface expression compared with the WT receptor [17] . Because of the decreased cell-surface expression, it is difficult to clearly characterize the role of b 1 AR glycosylation in receptor signaling and receptor cell-surface dimerization.
In this study, we mainly explored the relationship between cAMP production and b 2 AR dimerization, while the accurate molecular mechanism for the other signaling pathway needs to be further studied. It should be noted that the glycoform of the receptor may exist as complex type N-glycans, as PNGase F but not Endo-A digestion caused changes in receptor homodimer signal (Fig. 5E ). It will also be important to analyze the glycoform of the b 2 AR N-glycosylation to elucidate the exact role of N-glycosylation in receptor dimerization in the future.
Materials and methods

Plasmid constructs
All b 2 AR mutants were introduced into mammalian plasmid vectors (pCDNA3 and pFLAG-cmv4). Mutagenesis was performed using KOD-Plus DNA polymerase (TOYOBO) and Mut Express TM Multis Fast mutagenesis kit (Vazyme, Nanjing, China) according to the manufacturer's instructions. The identities of all of the mutant b 2 AR constructs were confirmed by sequencing the entire coding sequences by Genewiz.
Cell culture and transfection
HEK293 cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). The cells were cultured at 37°C in humidified incubators with 5% CO 2 and 95% air. For western blot, Tag-lite, flow cytometry, BS 3 crosslinking, fluorescence ligand-binding assay, and cAMP assays, HEK293 cells were transiently transfected with the receptor constructs using Lipofectamine Ò 2000 (Life Technologies, Shanghai, China).
Flow cytometry 
Western blot
Approximately 24 h after transfection, HEK293 cells were washed three times with phosphate buffer saline (PBS) and then lysed with CelLytic TM M cell lysis buffer (Sigma) for 10-min incubation on ice. The cells were scraped off from the dishes, collected into new 1.5 mL tubes, and incubated for 30 min on ice. Then, the lysates were centrifuged at 13 800 g for 5 min at 4°C. The supernatant was transferred to a new 1.5 mL tube and mixed with nonreducing SDS/PAGE sample buffer (Beyotime, Shanghai, China). The samples were then subjected to SDS/PAGE, transferred to Polyvinylidene Fluoride membrane and blotted with primary antibody (anti-HA, 1 : 500, Cell Signaling Technology, Shanghai, China) and horseradish peroxidase-linked secondary antibody (1 : 5000, Cell Signaling Technology) for chemiluminescence detection. Chemiluminescence was done on a FluorChem FC3 (Protein Simple, Silicon Valley, CA, USA).
Glycosidase digestion
HEK293 cells expressing the wild-type or mutant b 2 AR were digested with a nonenzyme cell dissociation solution (Sigma) and collected into new 1.5 mL tubes. After washing with PBS, the cells were incubated with PNGase F or Endo-A from Arthrobacter protophormiae, which were expressed following reported methods [25, 46] , for approximately 2 h at 37°C in an appropriate pH buffer. After enzyme digestion, the cells were processed for western blot or receptor homodimerization assay. The enzyme activities of Endo-A and PNGase F were confirmed by deglycosylation assays against the corresponding substrates prior to use. Endo-A indicated efficient deglycosylation of highmannose type N-glycans on ribonuclease B [47] within 5 min and PNGase F completely hydrolyzed the biantennary complex type N-glycan from a sialoglycopeptide extracted from egg yolks [48] in 2 h.
BS 3 crosslinking
HA-tagged b 2 AR was transfected in HEK293 cells for 24 hours. The cells were incubated with 1 mM BS 3 (Thermo Scientific Pierce, Shanghai, China) in PBS (pH 8.0) for 1 h at room temperature [32] , terminated by adding 50 mM Tris-HCl (pH 7.5). The cells were digested with nonenzyme cell dissociation solution (Sigma) and collected into new 1.5-mL tubes. Then, the cells were repeated freezing and thawing in liquid nitrogen and 37°C for three times. After centrifugation at 4°C, 17 250 g for 30 min, we washed the precipitate for three times with PBS. The cell membrane precipitate was lysed in CelLytic TM M cell lysis buffer (Sigma) and immunoprecipitated using EZview TM Red Anti-HA Affinity Gel (Sigma). The immunoprecipitated receptors were resolved by SDS/PAGE and detected with the anti-HA antibody.
Co-immunoprecipitation
Twenty-four hours post-transfection, cell membrane was prepared as described in BS 3 crosslinking. The cell membrane proteins were solubilized for 1 h at 4°C in CelLytic TM M cell lysis buffer. The solubilized receptor was immunoprecipitated using EZview TM Red ANTI-FLAG Ò M2 Affinity Gel (Sigma) with end-over-end rotation at 4°C. After four washes with 0.5 mL of lysis buffer, the immunoprecipitated proteins were eluted from the beads with 19 SDS/PAGE sample buffer, resolved by SDS/ PAGE, and subjected to western blot analyses.
cAMP assay HEK293 cells were cultured in 6-well plates. About 24 hours after transfection, the cells were incubated with nonenzyme cell dissociation solution (Sigma) at 37°C for 15 min. After centrifugation, the cells were suspended in DMEM (without FBS) containing 500 lM 3-isobutyl-1-methylxanthine (Sigma). Then, the cells were transferred into a 384-well plate at a density of 8000 cells per well. The cells were treated with isoproterenol at room temperature for 30 min. Then, the cells were incubated with cAMP-D 2 and anti-cAMP Crypate (cAMP kit, Cisbio, Shanghai, China) for 1 h at room temperature and readout using PerkinElmer Envision.
Receptor homodimerization assay
Twenty-four hours after transfection of HEK 293 cells with plasmids encoding SNAP-tag fusion proteins, we removed the cell culture medium (100 000 per well of a Greiner CellStar 96-well plate) and labeled cells with a mix of 100 nM of SNAP-Lumi4 Ò -Tb and 100 nM of SNAP-Red (Cisbio), which was previously diluted in Tag-lite labeling medium (Cisbio), for 1 h at 37°C. We washed the cells three times with Tag-lite labeling medium and measured the specific fluorescence signal of the Lumi4 Ò -Tb and Red at 620 and 665 nm, with excitation at 337 and 620 nm, respectively (mock-transfected cells as control).
Fluorescent ligand-binding assays
After SNAP-Lumi4 Ò -Tb labeled and nonenzyme cell dissociation solution (Sigma) digestion, HEK293 cells were suspended in Tag-lite labeling medium (10 000 cells per well for 384-well plates). The affinity of the fluorescence ligand for b 2 AR was determined by incubating the cells at room temperature with increasing concentrations of b 2 AR green antagonist (green-propranolol) (Cisbio). The nonspecific binding was determined by adding an excess of unlabeled propranolol at final concentration 10 À4 M. In plates containing labeled cells and 10 lL of Tag-lite labeling medium, 5 lL of unlabeled compound or Tag-lite labeling medium was added, followed by the addition of 5 lL fluorescent ligand. Plates were then incubated at room temperature for 2 h before signal detection [49] .
Confocal microscopy
HEK293 cells were plated into 8-well chambers (Thermo, NUNC) and co-transfected with pCDNA3-HA-b 2 AR and pEGFP-N1-b-arrestin2 using Lipofectamine Ò 2000 (1 : 2 ratio) for each well. Twenty-four hours post-transfection, the cells were incubated with 10 lM isoproterenol. Immobilization was taken at 1-min intervals for 20 min after stimulation. The cells were fixed with 4% paraformaldehyde (PFA) at 4°C for 15 min [24] and then washed with PBS three times and stored in 100 lL PBS. The cells were visualized using an Olympus FV100 inverted confocal microscope (Olympus, Shanghai, China).
Internalization
Internalization was carried out with previously described methods [24, 50] . FLAG-tagged receptors expressed in HEK293 cells in 12-well plates were treated with or without agonist for 30 min in serum-free medium at 37°C. Cell-surface receptors were labeled with monoclonal ANTI-FLAG Ò M2-FITC antibody (Sigma). Receptor internalization was quantified as the loss of cell-surface receptors, as measured by flow cytometry (FACS Calibur, BD Bioscience).
Statistical analysis
Statistical analyses were performed with PRISM software (GraphPad Software, San Diego, CA, USA). Data from two groups were compared by Student's t-test. A P value of < 0.05 was considered to be statistically significant.
